Evidence map›Paper›PMID 40692683›Full record

SynthesisFrontiers in cellular and infection microbiology2025

The impact of

Alia Albush, Fayez Yassine, Hassan Abbas, Aya Hanna, Esber Saba, Melhem Bilen

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Materials today. Bio · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. The importance ofFrontiers in gastroenterology (Lausanne, Switzerland) · 2026
    Review
  10. BeyondMedicina (Kaunas, Lithuania) · 2025
    Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alia AlbushDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Fayez YassineDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Hassan AbbasDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Aya HannaDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Esber SabaDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Melhem BilenDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: A systematic review was conducted across PubMed, Scopus, and Web of Science databases using predefined keywords and Medical Subject Headings (MeSH) terms. Quality assessment was performed using the MINORS and Jadad scales. Results: A total of 45 studies met the inclusion criteria, which evaluated microbial changes in Conclusion:

Indexed as

DysbiosisGastrointestinal MicrobiomeHelicobacter InfectionsHelicobacter pyloriStomach NeoplasmsAnti-Bacterial AgentsCarcinogenesisHumansProbioticsAnti-Bacterial Agentseradication therapiesgastric cancergut microbiotaH. pyloriprobiotics

Identifiers

PMID40692683
PMCPMC12277284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.